PlainRecalls

Camber Pharmaceuticals Inc.

Compiled from official public sources by the publisher.

5 recalls on record · Latest: May 17, 2023

Subscribe to new Camber Pharmaceuticals Inc. recalls (RSS)

Agency notice ledger

Federal filing book Camber Pharmaceuticals Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,405 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,405 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Drug (5)
  • CAT drugs
  • CATS 2 categories
  • LATEST May 17, 2023
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Camber Pharmaceuticals Inc. accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Camber Pharmaceuticals Inc. sits among 14,151 recalling firms

Camber Pharmaceuticals Inc. ranks 2,405th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Camber Pharmaceuticals Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2405th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Camber Pharmaceuticals Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Camber Pharmaceuticals Inc. holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Critical May 17, 2023

Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.
FDA Drug Low Dec 21, 2022

Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26
FDA Drug Moderate Mar 27, 2019

Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000 count (NDC 31722-701-10) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India
FDA Drug Moderate Mar 27, 2019

Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 1000 count (NDC 31722-702-10) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India
FDA Drug Moderate Mar 27, 2019

Losartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDC 31722-700-05) and c) 1000 count (NDC 31722-700-05) bottles, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar -509 301, India

Camber Pharmaceuticals Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Apace Ky LLC 5 Astellas Pharma US Inc. 5 AstraZeneca Pharmaceuticals LP 5 Atlantic Management Resources Ltd. 5

Frequently Asked Questions

How many federal recall notices name Camber Pharmaceuticals Inc.? ▼
PlainRecalls indexes 5 distinct federal recall events naming Camber Pharmaceuticals Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Camber Pharmaceuticals Inc. sit among other recalling firms? ▼
Camber Pharmaceuticals Inc. ranks #2,405 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Camber Pharmaceuticals Inc.'s notices? ▼
FDA Drug accounts for 5 of this firm's 5 indexed notices.
What product category dominates Camber Pharmaceuticals Inc.'s filing book? ▼
Filings for Camber Pharmaceuticals Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Camber Pharmaceuticals Inc.: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Camber Pharmaceuticals Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026